Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.
about
Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophreniaNitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated geneTherapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.The treatment of multiple sclerosis with inosineNeuroprotection and antioxidantsLipoxins: nature's way to resolve inflammationMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesBreakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cellsNeurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravoneExtra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Uric acid as a CNS antioxidantUric acid protects against secondary damage after spinal cord injury.Effect of mode of birth on purine and malondialdehyde in umbilical arterial plasma in normal term newbornsLipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Altered serum uric Acid level in lichen planus patients.Protein tyrosine nitration in cellular signal transduction pathways.Nitric oxide metabolites induced in Anopheles stephensi control malaria parasite infection.Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse modelsUric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic DisordersRole of xanthine oxidoreductase as an antimicrobial agent.Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. Implications for multiple sclerosisLigation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells.Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells.Effect of short-term maximal exercise on biochemical markers of muscle damage, total antioxidant status, and homocysteine levels in football players.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Diet, urate, and Parkinson's disease risk in men.Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability.Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductaseHybrid nanocrystals: University of Kentucky US20060280680A1.Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitisMitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS.Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virusEndothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.
P2860
Q21562668-4F5D0CB2-9587-4AC7-AB49-3A50B262C2FEQ24294779-BE436587-1898-4279-9AD8-B5C14F065A48Q24541522-368547E8-11B2-4B26-831F-74AE584BE72EQ24635190-6D9B80B0-DB00-47EF-A57A-A0CDFCC26544Q26740098-3914F033-91CA-4AB1-A32F-1747453DE717Q26784376-D507E64E-51ED-4B15-ABB5-204F2D4D8090Q27023735-24D8CD3C-C242-4C7F-8F68-3DD24E97BC7EQ28478219-ED6B3001-FD40-4C63-ABDB-8ECD629EF8A2Q28484248-2E493594-1DD3-468D-BAC5-12145C83E367Q28575931-4C675A08-F7FF-4740-8F86-C61B013E3438Q33350202-8678F25D-91F1-47CA-B178-4DB4A21260E5Q33758969-0A9947E7-6437-4ADC-9803-04524E815741Q33808567-258211F5-75B7-4877-A74F-7D98AF8FE090Q33927539-781D8196-B037-4FDE-9BCB-A437CDD742F2Q34152693-C41BDB74-4660-424D-AC29-067ACC7ED26FQ34192460-252A860A-934A-4451-9151-418B36A756EFQ34351848-BFED07B8-03F3-440B-815F-107F03E4E667Q34591474-373A2A39-3714-49AD-97CE-C29FE7E9D964Q34872656-CDF4DAAA-78DF-439E-B04C-448DA6F84518Q35574449-3A6CEEF9-DC3E-4D92-8FB8-B47FC1F93DEEQ35720175-9F688C58-90B1-4961-8B69-97ADF9BEA613Q35856483-9217B68E-CDC8-4A09-9BFD-8022FA7323FAQ35867860-ADB02592-2918-4A69-AB28-AE11823100B2Q35956034-440E16FA-F1D9-43A8-9947-DCEBB8C0D3D8Q36091937-2CE8CAB1-568E-4950-9ACF-F61D9BA5E9D0Q36091942-309B3D86-F0BE-4F33-8DEE-579BCEF680E0Q36476589-A68A49D0-E35E-465A-B7DC-F782C6B279E7Q36484413-1088CFE5-9282-4824-8648-CD51AA478903Q36632177-103909A6-3B79-49F7-8BEC-761ECE61AFB2Q36663760-ABA1AA97-5F8E-419D-A51D-EC174255E678Q36798405-69494AA4-A354-45AE-8DCB-B37D008D7087Q36926813-09208EFD-4793-47F5-A35A-D6084908E804Q36956768-084453C5-9917-48CD-BB5B-166BF84D7D36Q36984844-5707DA5D-782A-4ECE-BEDB-9A3BFF7E028BQ37093395-26D3FA32-C36A-4AC4-9FF1-ACF408BD0DACQ37157238-DD1E450F-BCAA-47CB-B265-46E293CD1EB5Q37217374-DBC1383F-B2AF-4E00-AA98-5D0F4FC6373FQ37251714-8714347B-3894-444E-A946-B1544E05B9D0Q37253355-4E61D635-14C1-492F-BBB5-79DFEFD7C750Q37334625-DADB71B4-743D-4DE7-9795-799DBF113EC0
P2860
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@ast
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@en
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@nl
type
label
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@ast
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@en
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@nl
prefLabel
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@ast
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@en
Uric acid, a peroxynitrite sca ...... e model of multiple sclerosis.
@nl
P2093
P356
P1433
P1476
Uric acid, a peroxynitrite sca ...... se model of multiple sclerosis
@en
P2093
D C Hooper
H Koprowski
S V Spitsin
T Mikheeva
P304
P356
10.1096/FASEBJ.14.5.691
P407
P577
2000-04-01T00:00:00Z